Kairos Pharma CEO to Present Corporate Strategy at Lytham Partners Healthcare Summit
Kairos Pharma (NYSE American: KAPA) has announced its participation in the upcoming Lytham Partners Investor...
Kairos Pharma (NYSE American: KAPA) has announced its participation in the upcoming Lytham Partners Investor...
GRI Bio (NASDAQ: GRI), a biotechnology company focused on developing Natural Killer T (NKT) cell...
In business development, the past, present and future all hold valuable lessons. Past habits can sometimes haunt us, current best...